Octapharma Canada Inc.
25 King Street West, Toronto, ON M5L 1G1, Canada
Please sign up here to receive email updates.
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings, add animations, add shape dividers, increase engagement with call to action and more.
Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings and more.
Change the color to match your brand or vision, add your logo, choose the perfect layout, modify menu settings and more.
“Solvent-detergent treatment is the current gold standard for safety from the highly infectious enveloped viruses, and should be seriously considered as the option of choice when assessing products.” 3
"Solvent-detergent treatment is the current gold standard for safety from the highly infectious enveloped viruses..."3
"Solvent/detergent treatment is gentle on plasma proteins while effective in eliminating enveloped viruses."2
Solvent/detergent reagents irreversibly disrupt the lipid membranes of all enveloped viruses (e.g., SARS-CoV-2, HIV, HBV, HCV, HGV, and CMV).4
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Standardized levels of neutralizing antibodies in the plasma pool minimize the risk of transmitting non-enveloped viruses (e.g., HAV, parvovirus B19, HEV).6
Adapted from Octapharma data on file.
This website contains information that Healthcare Professionals will need to successfully transition from transfusable plasma (FP) to pathogen inactivated plasma- Octaplasma®